New species of Hyphessobrycon from the Rio Teles Pires, Rio Tapajós basin, Brazil (Ostariophysi, Characiformes).

A new species of Hyphessobrycon from the upper Rio Tapajós basin, in the Tapajós-Juruena ecoregion, is described. Hyphessobrycon pinnistriatus n. sp. is distinguished from its congeners by having a black, oblique stripe extending from the origin of the second branched ray to the distal end of the third branched anal-fin ray, lacking a conspicuous black midlateral stripe on the body, inner premaxillary teeth with up to seven cusps, and fins normally hyaline or with scattered chromatophores. The description of a new species that is restricted to the Tapajós-Juruena ecoregion is consistent with this region being an area of high endemism of freshwater fishes.

Comportamento ingestivo e parâmetros sanguíneos em ovinos que receberam dietas contendo aditivos à base de extratos de própolis em pó / Ingestive behavior and blood profile in sheep fed with diets containing powdered propolis extract additives

Objetivou-se avaliar os efeitos do extrato de própolis (LLOSC2) sobre o comportamento ingestivo e os parâmetros sanguíneos em cordeiros alimentados com dieta concentrada. Foram utilizados quatro cordeiros machos, castrados, sem raça definida e com peso médio inicial de 32±1,92kg, mantidos em gaiolas metabólicas individuais durante todo o período experimental. O delineamento experimental foi em quadrado latino 4x4, com quatro animais, quatro dietas e quatro períodos experimentais. As dietas diferiram em relação à adição ou não de extratos de própolis à ração. As dietas testadas diferiam na adição de zero (controle), 1(88,16mg/g de flavonoides), duas (176,32mg/g de flavonoides) ou três (264,48mg/g de flavonoides) doses de aditivo à base de extrato de própolis LLOSC2. A dieta tinha relação volumoso:concentrado de 40:60 e foi formulada para ganhos de 250g. A ração concentrada era composta de milho e farelo de soja. O comportamento ingestivo dos animais foi observado por 24 horas, divididas em quatro períodos de seis horas. As coletas de sangue eram realizadas no último dia do período. Não houve efeito das doses LLOSC2 sobre o tempo despendido em alimentação, ruminação, ócio e ingestão de água. A duração do ciclo ruminativo foi maior nos animais que receberam duas doses de LLOSC2, e o número de movimentos mastigatórios também tendeu a aumentar no período que compreendia das 13 às 19h. Já a dieta contendo uma dose de LLOSC2 aumentou a duração da ruminação do bolo bem como o seu número total de mastigações no período de uma a sete horas. Houve uma diminuição nos níveis séricos de cortisol com a adição de três doses de LLOSC2. O hemograma, o leucograma, o perfil bioquímico e as imunoglobulinas não foram afetados pela inclusão das doses de LLSOC2. A administração de extrato de própolis LLOSC2 à dieta de ovinos não afetou seu comportamento ingestivo, os parâmetros hematológicos, bioquímicos e imunológicos estudados.(AU)

The objective of this study was to evaluate the effects of propolis extract (LLOS 2) on feeding behavior and blood parameters in lambs fed concentrate diet. Four male lambs were castrated, mongrel and average weight of 32±1.92kg, kept in individual metabolic cages throughout the trial period. The experimental design was a Latin square 4 x 4 with four animals, four treatments and four experimental periods. The diets differed according to addition or not of propolis extracts to feed. The experimental diets differed in addition to zero (control), 1 (88.16mg/g flavonoids) 2 (176.32mg/g flavonoids) or 3 (264.48mg/g flavonoids) Additive doses based on LLOSC2 propolis extract. The diet had a forage:concentrate ratio of 40:60 and was formulated to 250g gains. The concentrate ration was composed based on corn and soybean meal. The feeding behavior of the animals were observed for 24 hours, divided into four periods of 6 hours. Blood collections were made on the last day of the period. There was no effect of LLOSC2 doses on time spent eating, ruminating, leisure and water intake. The duration of the ruminative cycle was higher in animals that received two doses of LLOSC2 and the number of chewing movements also tended to increase in the period comprised from 13 to 19h. Since the diet containing a dose of LLOSC2, increased duration of rumination cake as well as its total number of chewing in the period of 1 to 7 hours. There was a decrease in serum cortisol with the addition of three doses of LLOSC2. The blood count, white blood cell count, biochemical profile and immunoglobulins were not affected by the inclusion of doses of LLSOC2. Administration of LLOSC2 propolis extract the sheep diet did not affect their feeding behavior, hematological, biochemical and immunological studies.(AU)

Chemokine Patterns in Children with Acute Bacterial Infections.

Chemokines are chemotactic cytokines that are mainly involved in the migratory patterns of immune cells. Few studies have evaluated the levels of chemokines in children with acute bacterial infections. The aim of this study was to evaluate the serum levels of chemokines MCP-1, RANTES, MIG and IP-10 in children with sepsis, community-acquired pneumonia (CAP) and skin abscess. Serum levels of MCP-1, RANTES, MIG and IP-10 were measured in 37 children with sepsis, 27 children with CAP, 25 children with skin abscess and 20 controls with no signs of infection. Patients with sepsis, CAP and skin abscess had higher concentrations of RANTES compared to controls (P = 0.0057, P = 0.0004 and P = 0.0108, respectively). IP-10 values were higher in patients with sepsis compared to children with skin abscess (P = 0.0075). However, MCP-1 levels were lower in septic patients compared to controls (P = 0.0136). There was no difference on MIG concentrations between the groups. Our original findings observed that RANTES was consistently elevated in all types of infections suggesting this chemokine may play an important role in the pathogenesis of bacterial infection. Additionally, patients with sepsis had a unique pattern of response with high levels of IP-10 but low levels of MCP-1, which should be further explored as the markers of disease severity.

Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE.

The clinical expression of systemic lupus erythematosus (SLE) is influenced by genetic and environmental factors and therefore varies between ethnicities. Information on the epidemiology of SLE in Brazil is scarce and practically limited to studies conducted in socioeconomically developed regions (South and Southeast). The objective of this study was to describe the clinical and immunological aspects and outcome of a cohort of patients with SLE treated at a university hospital in northeastern Brazil and compare patterns related to age at onset: childhood (cSLE), adult (aSLE), and late (lSLE). A random sample of 414 records (women: 93.5%) were reviewed. The mean age at SLE onset and the mean disease duration were 28.9 ± 10.9 years and 10.2 ± 6.6 years, respectively. Most patients had aSLE (n = 338; 81.6%), followed by cSLE (n = 60; 14.5%) and lSLE (n = 16; 3.9%). The female/male ratio was 6.5:1 in cSLE and 16.8:1 in aSLE; in lSLE, all patients were female (p = 0.05). During follow-up, the cSLE group presented higher rates of nephritis (70% vs. 52.9% vs. 12.5%; p = 0.0001) and leuko/lymphopenia (61.7% vs. 43.8% vs. 56.2%; p = 0.02). No significant differences were found for anti-dsDNA, anti-Sm, and antiphospholipid antibodies. Treatment with immunosuppressants was significantly more common, and higher doses of prednisone were used, in cSLE. The prevalence of cardiovascular diseases were more frequent in lSLE (p = 0.03). No significant differences were found between the three groups with regard to mean damage accrual (SDI), remission, and mortality. Although cSLE presented higher rates of nephritis and leuko/lymphopenia, more frequent use of immunosuppressants and higher prednisone doses than aSLE and lSLE, the three groups did not differ significantly with regard to damage accrual, remission, and mortality.